Psoriasis, Fibroxanthomas, AI & More| July 22, 2026 | Ep. 84, Issue 114

Join host Karla Mandima and dive sk(in depth) into the latest dermatology research with 8 new articles!Listen to learn more about: Does tuberculosis risk differ across systemic dermatology therapies?Elevated skin cancer risk among female patients with systemic sclerosis and organ transplantation.Oral icotrokinra sustains high rates of clear skin and symptom relief through one year, with comparable safety to placebo.Most children with psoriasis maintained remission after stopping systemic therapy.Atypical fibroxanthomas can be differentiated from melanoma by positive CD10 and negative PRAME expression.Simple changes in dermatologic surgery can reduce environmental waste while maintaining patient safety.Fractionated laser therapy is effective at decreasing melasma-related skin pigmentation in patients with Fitzpatrick skin type III-IV.Skin tone bias in AI-generated images of autoimmune skin disease.For questions, comments or future episode suggestions, please email us at [email protected] with sk(in depth):Website: ⁠⁠⁠⁠⁠⁠⁠https://www.skindepthderm.com/Instagram: @skindepthdermTwitter: @skindepth_derm-Music Credits: Tropical Vibe by WinnieTheMoogLink: ⁠⁠⁠⁠⁠⁠⁠https://filmmusic.io/song/10446-tropical-vibe⁠⁠⁠⁠⁠⁠⁠License: ⁠⁠⁠⁠⁠⁠⁠https://filmmusic.io/standard-license